Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
10x Genomics

10x Genomics

Single-cell precision diagnostics

Pleasanton, California, US

An American biotechnology company that designs and manufactures sequencing technologies focused on single-cell and spatial omics for scientific research, providing integrated solutions including instruments, consumables, and software.

Hero image for 10x Genomics
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in 10x Genomics
Claim This Profile →

How We Help

Problem Statement

Researchers need advanced technologies to analyze complex biological systems at a single-cell and spatial level to gain deeper insights into disease mechanisms and accelerate drug development.

Core Technology

microfluidics-based method of single-cell RNA sequencing, Chromium system, Next GEM technology, Chromium platform for single-cell sequencing applications (scRNA-seq, scATAC-seq, scMultiome)

Key Differentiators

Focus on single-cell and spatial omics for scientific research; Microfluidics-based method of single-cell RNA sequencing; Integrated solutions including instruments, consumables, and software; Chromium system and Next GEM technology; Chromium platform supports various single-cell sequencing applications (scRNA-seq, scATAC-seq, scMultiome)

Clinical Focus

Diagnostics

Company Info

Business Model
Hybrid
Total Funding
250,000,000
Website
10xgenomics.com

Categories

Precision Medicine/Diagnostics

Disease Areas

Technologies

single-cell sequencingspatial omicsmicrofluidicsgenomicsbiotechnologyscRNA-seqscATAC-seqscMultiomeSingle cell genomicsSpatial genomicsMultiomicsBioinformaticsLife sciencesGene sequencingSingle-cell sequencingSpatial transcriptomicsGenomicsLife science tools

Clinical & IP

🔬

Clinical Validation

Announced 2026 clinical entry at JPMorgan with three major academic partnerships. CLIA lab launch planned. Active biomarker research correlating single-cell data to clinical outcomes.

MedStartr Index Score

?
57

What do you think of 10x Genomics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in 10x Genomics